ALI in Cancer Patients

The aim of the study is to describe and evaluate the outcomes of cancer patients presenting with and treated for ALI at our center .

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Acute Limb Ischemia

Sex eligibility

All sexes

Study type

Observational

About this study

Acute limb ischemia (ALI) is a vascular emergency and is associated with significant morbidity and mortality. Peripheral arterial embolism or thrombosis from malignant disease is uncommon and a rare cause of acute limb ischemia. Limb ischemia can be caused by emboli from the tumor itself, from metastatic deposits within large vessels, as well as the tumors of adjacent organs such as the lung, which invade the left or right atrium of the heart and then disseminate to the main arteries of the body. This acute event may be the first indication of malignant disease in the patient.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All cancer patient presented to Vascular and Endovascular surgery departement with ALI.

Exclusion criteria

Patients with benign tumors or without active malignancy.
Patients with iatrogenic limb ischemia related to a tumor chemoembolization procedure.

Treatment and study plan

Primary outcomes

Limb Salvage

Time frame: baseline

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Outcomes of Acute Limb Ischemia in Cancer Patients .

Acronym: ALI

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Mar 18, 2025
Registry last updated: Mar 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting